Order Article Reprints

Sajesh BV, On NH, Omar R, Alrushaid S, Kopec BM, Wang W-G, Sun H-D, Lillico R, Lakowski TM, Siahaan TJ, et al. Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors. Pharmaceutics. 2019; 11(9):481. https://doi.org/10.3390/pharmaceutics11090481

Sajesh, Babu V., Ngoc H. On, Refaat Omar, Samaa Alrushaid, Brian M. Kopec, Wei-Guang Wang, Han-Dong Sun, Ryan Lillico, Ted M. Lakowski, Teruna J. Siahaan, and et al. 2019. "Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors" Pharmaceutics 11, no. 9: 481. https://doi.org/10.3390/pharmaceutics11090481

Sajesh, B. V., On, N. H., Omar, R., Alrushaid, S., Kopec, B. M., Wang, W.-G., Sun, H.-D., Lillico, R., Lakowski, T. M., Siahaan, T. J., Davies, N. M., Puno, P.-T., Vanan, M. I., & Miller, D. W. (2019). Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors. Pharmaceutics, 11(9), 481. https://doi.org/10.3390/pharmaceutics11090481